Patent Assignment
Reel/Frame 048691/0028
Assignment of Assignor's Interest
Recorded: 2019-03-25
Pages: 10
Assignor
FWP IP APS
Executed: 2019-03-25
Assignee
BIOGEN SWISS MANUFACTURING GMBH
NEUHOFSTRASSE 30, BAAR, 6340, SWITZERLAND
Covered Properties
(47)
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester ("480 Mg Per Day Dosing")
Application:
11/576,871 →
Publication:
US 2009/0304790
Combination Therapy with Fumaric Acid Esters for the Treatment of Autoimmune and/or Inflammatory Disorders
Application:
12/089,004 →
Publication:
US 2008/0300217
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
12/089,074 →
Publication:
US 2008/0299196
Pharmaceutical Composition Comprising One or More Fumaric Acid Esters
Application:
13/143,465 →
Publication:
US 2012/0034274
Pharmaceutical Formulation Comprising One or More Fumaric Acid Esters in an Erosion Matrix
Pharmaceutical Composition Comprising One or More Fumaric Acid Esters
Application:
13/768,829 →
Publication:
US 2013/0259906
CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER ("Uptitration regimen including 480 mg per day dosing")
Application:
13/957,117 →
Publication:
US 2014/0037720
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
13/957,147 →
Publication:
US 2013/0315993
CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER ("Cmax and 480 mg per day dosing")
Application:
13/957,220 →
Publication:
US 2013/0316003
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
13/957,250 →
Publication:
US 2014/0037740
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
14/209,480 →
Publication:
US 2014/0193495
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
14/209,584 →
Publication:
US 2014/0200272
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
14/209,651 →
Publication:
US 2014/0200273
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
14/209,712 →
Publication:
US 2014/0199386
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
14/209,756 →
Publication:
US 2014/0199393
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
14/209,823 →
Publication:
US 2015/0024049
Methods for treating multiple sclerosis
Application:
14/212,503 →
Publication:
US 2014/0199390
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
14/212,685 →
Publication:
US 2014/0199392
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
14/213,321 →
Publication:
US 2014/0199387
Methods for treating multiple sclerosis
Application:
14/213,399 →
Publication:
US 2014/0205659
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
14/213,673 →
Publication:
US 2014/0199388
Combination Therapy for Treatment of Multiple Sclerosis
Application:
14/419,031 →
Publication:
US 2015/0164849
Pharmaceutical Formulation Comprising One or More Fumaric Acid Esters in an Erosion Matrix
Application:
14/561,010 →
Publication:
US 2015/0272894
Pharmaceutical Composition Containing Dimethyl Fumarate for Administration at a Low Daily Dose
Application:
14/914,025 →
Publication:
US 2016/0206586
Pharmaceutical Composition Containing Dimethyl Fumarate for Administration at a Low Daily Dose
Application:
14/914,031 →
Publication:
US 2016/0206587
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
15/581,966 →
Publication:
US 2017/0231941
Pharmaceutical Composition Containing Dimethyl Fumarate for Administration at a Low Daily Dose
Application:
15/584,439 →
Publication:
US 2017/0231943
Pharmaceutical Composition Containing Dimethyl Fumarate for Administration at a Low Daily Dose
Application:
15/723,749 →
Publication:
US 2018/0021289
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
15/728,872 →
Publication:
US 2018/0028483
Combination Therapy for Treatment of Multiple Sclerosis
Application:
15/807,878 →
Pharmaceutical Composition Containing Dimethyl Fumarate for Administration at a Low Daily Dose
Application:
15/834,799 →
Publication:
US 2018/0092875
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
15/834,870 →
Publication:
US 2018/0098957
Pharmaceutical Formulation Comprising One or More Fumaric Acid Esters in an Erosion Matrix
Application:
15/945,005 →
Publication:
US 2018/0221284
Pharmaceutical Composition Containing Dimethyl Fumarate for Administration at a Low Daily Dose
Application:
15/979,894 →
Publication:
US 2018/0256530
Combination Therapy for Treatment of Multiple Sclerosis
Application:
15/988,177 →
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
15/988,628 →
Publication:
US 2018/0263947
Pharmaceutical Composition Containing Dimethyl Fumarate for Administration at a Low Daily Dose
Application:
16/046,028 →
Publication:
US 2018/0338946
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
16/046,509 →
Publication:
US 2018/0325855
Pharmaceutical Formulation Comprising One or More Fumaric Acid Esters in an Erosion Matrix
Combination Therapy for Treatment of Multiple Sclerosis
Application:
16/202,851 →
Publication:
US 2019/0091190
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
16/204,403 →
Publication:
US 2019/0091191
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
16/204,503 →
Publication:
US 2019/0091192
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
16/204,559 →
Publication:
US 2019/0091193
Pharmaceutical Composition Containing Dimethyl Fumarate for Administration at a Low Daily Dose
Application:
16/227,089 →
Publication:
US 2019/0125711
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
Application:
16/294,038 →
Publication:
US 2019/0201368
Pharmaceutical Composition Containing Dimethyl Fumarate for Administration at a Low Daily Dose
Application:
16/294,515 →
Publication:
US 2019/0201369
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 27, 2007
From: NILSSON, HENRIK; SCHOENHARTING, FLORIAN; MUELLER, BERND W.; LEGAL HEIR TO JOSEPH R. ROBINSON (DECEASED), BONNA ROBINSON
To: ADITECH PHARMA AB
Reel/Frame 019484/0642 →
Assignment of Assignor's Interest
May 28, 2008
From: NILSSON, HENRIK
To: ADITECH PHARMA AB
Reel/Frame 021009/0834 →
Assignment of Assignor's Interest
May 28, 2008
From: NILSSON, HENRIK; MULLER, BERND W.
To: ADITECH PHARMA AB
Reel/Frame 021008/0444 →
Assignment of Assignor's Interest
Sep 2, 2009
From: ADITECH PHARMA AB
To: ADITECH PHARMA AG
Reel/Frame 023179/0978 →
Assignment of Assignor's Interest
Oct 14, 2010
From: ADITECH PHARMA AG
To: FORWARD PHARMA A/S
Reel/Frame 025140/0486 →
Assignment of Assignor's Interest
Oct 14, 2010
From: ADITECH PHARMA AG
To: FORWARD PHARMA A/S
Reel/Frame 025140/0665 →
Assignment of Assignor's Interest
Nov 2, 2011
From: NILSSON, HENRIK; RUPP, ROLAND
To: FORWARD PHARMA A/S
Reel/Frame 027163/0924 →
Assignment of Assignor's Interest
Nov 2, 2011
From: NILSSON, HENRIK; RUPP, ROLAND
To: FORWARD PHARMA A/S
Reel/Frame 027163/0909 →
Assignment of Assignor's Interest
Aug 27, 2013
From: ADITECH PHARMA AB
To: ADITECH PHARMA AG
Reel/Frame 031091/0261 →
Assignment of Assignor's Interest
Aug 27, 2013
From: NILSSON, HENRIK; SCHOENHARTING, FLORIAN; MUELLER, BERND W.; ROBINSON, JOSEPH R.
To: ADITECH PHARMA AB
Reel/Frame 031090/0885 →
Assignment of Assignor's Interest
Aug 27, 2013
From: ADITECH PHARMA AG
To: FORWARD PHARMA A/S
Reel/Frame 031095/0649 →
Assignment of Assignor's Interest
Feb 11, 2014
From: NILSSON, HENRIK; RUPP, ROLAND
To: FORWARD PHARMA A/S
Reel/Frame 032194/0047 →
Assignment of Assignor's Interest
Mar 21, 2014
From: NILSSON, HENRIK; SCHOENHARTING, FLORIAN; MUELLER, BERND W.; ROBINSON, JOSEPH R.
To: ADITECH PHARMA AB
Reel/Frame 032493/0243 →
Assignment of Assignor's Interest
Mar 21, 2014
From: ADITECH PHARMA AG
To: FORWARD PHARMA A/S
Reel/Frame 032497/0406 →
Assignment of Assignor's Interest
Mar 21, 2014
From: ADITECH PHARMA AB
To: ADITECH PHARMA AG
Reel/Frame 032493/0838 →
Assignment of Assignor's Interest
May 11, 2015
From: TERWEY, THEIS; RUPP, ROLAND; ANDERSEN, PEDER M.
To: FORWARD PHARMA A/S
Reel/Frame 035607/0010 →
Assignment of Assignor's Interest
Jun 19, 2015
From: NILSSON, HENRIK; RUPP, ROLAND
To: FORWARD PHARMA A/S
Reel/Frame 035869/0485 →
Assignment of Assignor's Interest
Apr 11, 2016
From: GALETZKA, CHRISTIN; RUNDFELDT, CHRIS; RUPP, ROLAND; ANDERSEN, PEDER M.
To: FORWARD PHARMA A/S
Reel/Frame 038241/0949 →
Assignment of Assignor's Interest
Apr 11, 2016
From: GALETZKA, CHRISTIN; RUNDFELDT, CHRIS; RUPP, ROLAND; ANDERSEN, PEDER M.
To: FORWARD PHARMA A/S
Reel/Frame 038242/0029 →
Assignment of Assignor's Interest
Jun 9, 2017
From: NILSSON, HENRIK; RUPP, ROLAND
To: FORWARD PHARMA A/S
Reel/Frame 042755/0724 →
Assignment of Assignor's Interest
Jul 5, 2017
From: FORWARD PHARMA A/S
To: FORWARD PHARMA OPERATIONS APS
Reel/Frame 042903/0352 →
Assignment of Assignor's Interest
Jul 12, 2017
From: FORWARD PHARMA OPERATIONS APS
To: FWP IP APS
Reel/Frame 042987/0578 →
Assignment of Assignor's Interest
Oct 5, 2017
From: NILSSON, HENRIK; MUELLER, BERND W.
To: ADITECH PHARMA AB
Reel/Frame 043799/0557 →
Assignment of Assignor's Interest
Oct 5, 2017
From: ADITECH PHARMA AB
To: ADITECH PHARMA AG
Reel/Frame 043799/0686 →
Assignment of Assignor's Interest
Nov 9, 2017
From: ADITECH PHARMA AG
To: FORWARD PHARMA A/S
Reel/Frame 044079/0076 →